Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis.

Ikeda, Satoshi; Kato, Terufumi; Kenmotsu, Hirotsugu; Okamoto, Hiroaki; Ogura, Takashi

Ikeda, Satoshi; Kato, Terufumi; Kenmotsu, Hirotsugu; Okamoto, Hiroaki; Ogura, Takashi.

Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1, Tomioka-higashi, Kanazawa-ku, Yokohama-city, Kanagawa Prefecture, 236-0051, Japan. Electronic address: isatoshi0112@gmail.com.
Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama-city, Kanagawa Prefecture, 241-8515, Japan.
Kenmotsu H; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka Prefecture, 411-8777, Japan.
Okamoto H; Department of Respiratory Medicine and Medical Oncology, Yokohama Municipal Citizen's Hospital, 56, Okazawa-cho, Hodogaya-ku, Yokohama-city, Kanagawa Prefecture, 221-0855, Japan.
Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1, Tomioka-higashi, Kanazawa-ku, Yokohama-city, Kanagawa Prefecture, 236-0051, Japan.

Eur J Cancer ; 151: 249-251, 2021 07.

Article in English | MEDLINE | ID: covidwho-1272398

Subject(s)

Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Humans; Idiopathic Pulmonary Fibrosis/drug therapy; Immune Checkpoint Inhibitors; Lung Neoplasms/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis / Lung Neoplasms Limits: Humans Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google